Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity
about
Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001In vitro activity and spectrum of LY333328, a novel glycopeptide derivative.In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
P2860
Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity
description
1989 nî lūn-bûn
@nan
1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Effects of reduced cation supp ...... in antistaphylococcal activity
@ast
Effects of reduced cation supp ...... in antistaphylococcal activity
@en
type
label
Effects of reduced cation supp ...... in antistaphylococcal activity
@ast
Effects of reduced cation supp ...... in antistaphylococcal activity
@en
prefLabel
Effects of reduced cation supp ...... in antistaphylococcal activity
@ast
Effects of reduced cation supp ...... in antistaphylococcal activity
@en
P2860
P356
P1476
Effects of reduced cation supp ...... in antistaphylococcal activity
@en
P2093
P2860
P304
P356
10.1128/AAC.33.9.1652
P407
P577
1989-09-01T00:00:00Z